Salem Investment Counselors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-111
Closed -$3.11K – 460
2026
Q2
$3.11K Hold
111
– – ﹤0.01% 1063
2026
Q1
$3.17K Buy
+111
New +$3.79K ﹤0.01% 1028
2025
Q4
– Sell
-111
Closed -$3.91K – 440
2025
Q3
$3.91K Hold
111
– – ﹤0.01% 1011
2025
Q2
$3.64K Hold
111
– – ﹤0.01% 990
2025
Q1
$3.58K Buy
+111
New +$4.12K ﹤0.01% 969

Other funds holding ATRC

Salem Investment Counselors's ATRC Position: Q3 2026 in Review

Salem Investment Counselors sold out of AtriCure (ATRC) in Q3 2026, closing a stake of 111 shares — an estimated $3.11K sold.

Salem Investment Counselors first reported a position in ATRC in Q1 2025 and held it in 5 quarters. The position peaked at $3.91K in Q3 2025. 18 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Salem Investment Counselors reported no remaining AtriCure position as of Q3 2026 after selling out during the quarter.
  • Salem Investment Counselors sold 111 AtriCure shares in Q3 2026, an estimated $3.11K.
  • Salem Investment Counselors first reported a position in AtriCure in Q1 2025 and held it in 5 quarters.
  • Salem Investment Counselors's AtriCure position peaked at $3.91K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Salem Investment Counselors's 13F filing for Q3 2026, filed 13 Oct 2026.